Literature DB >> 27990672

Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination.

Falguni Basuli1, Xiang Zhang1, Carolyn C Woodroofe1, Elaine M Jagoda2, Peter L Choyke2, Rolf E Swenson1.   

Abstract

Fluorine-18 labeling of biomolecules is mostly performed by an indirect labeling method using a prosthetic group. Fluorine-18 labeled 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl ester is a useful prosthetic group to radiolabel a protein. Recently, we reported an improved preparation of this prosthetic group. To test the conjugation efficiency of the labeled ester prepared by this method, we have performed conjugation reactions with a peptide, a protein, and a small molecule. Prostate-specific membrane antigen targeting small molecule [18 F]DCFPyL, αvβ3 integrin receptors targeting peptide [18 F]c(RGDfK) and [18 F]albumin were prepared in good radiochemical yields. The conjugation reactions were completed at 40°C to 50°C in 10 minutes. The overall radiochemical yield was 25% to 43% in 30 to 45 minutes. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  F-18; peptide; protein; radiolabeling

Mesh:

Substances:

Year:  2017        PMID: 27990672      PMCID: PMC5344719          DOI: 10.1002/jlcr.3487

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  61 in total

1.  2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Authors:  Ying Chen; Mrudula Pullambhatla; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Srinivasan Senthamizhchelvan; George Sgouros; Ronnie C Mease; Martin G Pomper
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

2.  A two-step fluorinase enzyme mediated (18)F labelling of an RGD peptide for positron emission tomography.

Authors:  S Thompson; M Onega; S Ashworth; I N Fleming; J Passchier; D O'Hagan
Journal:  Chem Commun (Camb)       Date:  2015-09-11       Impact factor: 6.222

Review 3.  Current use of PSMA-PET in prostate cancer management.

Authors:  Tobias Maurer; Matthias Eiber; Markus Schwaiger; Jürgen E Gschwend
Journal:  Nat Rev Urol       Date:  2016-02-23       Impact factor: 14.432

4.  Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution.

Authors:  C S Levin; E J Hoffman
Journal:  Phys Med Biol       Date:  1999-03       Impact factor: 3.609

5.  Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.

Authors:  Zsolt Szabo; Esther Mena; Steven P Rowe; Donika Plyku; Rosa Nidal; Mario A Eisenberger; Emmanuel S Antonarakis; Hong Fan; Robert F Dannals; Ying Chen; Ronnie C Mease; Melin Vranesic; Akrita Bhatnagar; George Sgouros; Steve Y Cho; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

Review 6.  11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.

Authors:  Paola Mapelli; Elena Incerti; Francesco Ceci; Paolo Castellucci; Stefano Fanti; Maria Picchio
Journal:  J Nucl Med       Date:  2016-10       Impact factor: 10.057

7.  The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor.

Authors:  Goutam Mondal; Sugata Barui; Arabinda Chaudhuri
Journal:  Biomaterials       Date:  2013-05-21       Impact factor: 12.479

8.  Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.

Authors:  Aileen Höhne; Linjing Mu; Michael Honer; P August Schubiger; Simon M Ametamey; Keith Graham; Timo Stellfeld; Sandra Borkowski; Dietmar Berndorff; Ulrich Klar; Ulrike Voigtmann; John E Cyr; Matthias Friebe; Ludger Dinkelborg; Ananth Srinivasan
Journal:  Bioconjug Chem       Date:  2008-08-28       Impact factor: 4.774

9.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

10.  Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.

Authors:  Markus Dietlein; Carsten Kobe; Georg Kuhnert; Simone Stockter; Thomas Fischer; Klaus Schomäcker; Matthias Schmidt; Felix Dietlein; Boris D Zlatopolskiy; Philipp Krapf; Raphael Richarz; Stephan Neubauer; Alexander Drzezga; Bernd Neumaier
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

View more
  15 in total

1.  Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents.

Authors:  Jyoti Roy; Blake M Warner; Falguni Basuli; Xiang Zhang; Karen Wong; Thomas Pranzatelli; Anita T Ton; John A Chiorini; Peter L Choyke; Frank I Lin; Elaine M Jagoda
Journal:  Cancer Biother Radiopharm       Date:  2020-02-19       Impact factor: 3.099

Review 2.  18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography.

Authors:  Hema S Krishnan; Longle Ma; Neil Vasdev; Steven H Liang
Journal:  Chemistry       Date:  2017-09-01       Impact factor: 5.236

3.  Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios.

Authors:  Zhengyuan Zhou; Darryl McDougald; Nick Devoogdt; Michael R Zalutsky; Ganesan Vaidyanathan
Journal:  Mol Pharm       Date:  2018-11-28       Impact factor: 4.939

4.  Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using "radio-fluorination on the Sep-Pak" method.

Authors:  Falguni Basuli; Xiang Zhang; Elaine M Jagoda; Peter L Choyke; Rolf E Swenson
Journal:  J Labelled Comp Radiopharm       Date:  2018-05-01       Impact factor: 1.921

5.  Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model.

Authors:  Michael V Green; Jurgen Seidel; Mark R Williams; Karen J Wong; Anita Ton; Falguni Basuli; Peter L Choyke; Elaine M Jagoda
Journal:  Nucl Med Biol       Date:  2017-06-30       Impact factor: 2.408

6.  An azeotropic drying-free approach for copper-mediated radiofluorination without addition of base.

Authors:  Xiang Zhang; Falguni Basuli; Rolf E Swenson
Journal:  J Labelled Comp Radiopharm       Date:  2019-02-20       Impact factor: 1.921

7.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

8.  Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging.

Authors:  Jyoti Roy; Margaret E White; Falguni Basuli; Ana Christina L Opina; Karen Wong; Morgan Riba; Anita T Ton; Xiang Zhang; Keith H Jansson; Elijah Edmondson; Donna Butcher; Frank I Lin; Peter L Choyke; Kathleen Kelly; Elaine M Jagoda
Journal:  Mol Imaging Biol       Date:  2021-04-23       Impact factor: 3.488

Review 9.  Engineered antibodies: new possibilities for brain PET?

Authors:  Dag Sehlin; Stina Syvänen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

10.  Competitive blocking of salivary gland [18F]DCFPyL uptake via localized, retrograde ductal injection of non-radioactive DCFPyL: a preclinical study.

Authors:  Jyoti Roy; Blake M Warner; Falguni Basuli; Xiang Zhang; Changyu Zheng; Corrine Goldsmith; Tim Phelps; Karen Wong; Anita T Ton; Rick Pieschl; Margaret E White; Rolf Swenson; John A Chiorini; Peter L Choyke; Frank I Lin
Journal:  EJNMMI Res       Date:  2021-07-21       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.